Home » Market News » DirectorsTalk Highlights » Selena Gomez making amazing improvements with her lupus
Immupharma Plc

Selena Gomez making amazing improvements with her lupus

Selena Gomez has been making “amazing” strides toward bettering her health these days.

So far this year, Gomez has appeared on a handful of new songs, released a new movie, and has been hanging out with loved ones — like her cousin, Priscilla DeLeon, whom she served as Maid of Honor at her wedding. And now, according to E! News, Gomez also seems to be making incredible improvements with her lupus too.

Few AIM-listed drug development companies have late-stage clinical assets in the pipeline, ImmuPharma plc (LON:IMM) is an exception. The Company’s lead compound, Lupuzor™, a potential treatment for Lupus, has completed Phase 3 trial of dosing patients across the US, Europe and Mauritius with top line results announced.

To read the full news article please click here

Receive our exclusive interviews – Enter your email to stay up to date.

Disclaimer: Statements in this article should not be considered investment advice, which is best sought directly from a qualified professional.